Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-10-27
1996-11-12
Gupta, Yogendra N.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514323, 514322, 546187, A61K 31445, C07D40114
Patent
active
055740448
ABSTRACT:
Compounds, 1,3-dihydro-1-{1-[piperidin-4-yl]piperidin-4-yl}-2H-benzimidazol-2-ones and 1,3-dihydro-1-{4-amino-1-cyclohexyl}-2H-benzimidazol-2-ones and derivatives thereof, their preparation, method of use and pharmaceutical compositions are described. These compounds are endowed with antimuscarinic activity and are useful in the treatment and/or prevention of myopia (commonly known as nearsightedness).
REFERENCES:
patent: 4066772 (1978-01-01), Vandenberk et al.
patent: 5122522 (1992-06-01), Laties et al.
patent: 5284843 (1994-02-01), Stone et al.
Dorje et al., J. Phamacol. Exp. Ther. 256; 727-733 (1991).
Feifel et al., Brit. J. Pharmacol. 99; 455-460 (1990).
Bell Ian M.
Mallorga Pierre J.
Ransom Richard W.
Smith Anthony M.
Sugrue Michael F.
Ayler Sylvia A.
Daniel Mark R.
Gupta Yogendra N.
Merck & Co. , Inc.
LandOfFree
Muscarine antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Muscarine antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Muscarine antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-562840